Regeneus’ product pipeline consists of two platform technologies, Progenza™ and Sygenus, across three target therapeutic areas: osteoarthritis, neuropathic pain and skin wound healing. Progenza™Allogenic Adipose MSC plus MSC Secretions Secretome with Bioactive Molecules & Exosomes R&DPreclinicalPhase 1Phase 2Phase 3In-market OsteoarthritisNeuropathic Pain SygenusAllogenic Adipose MSC Secretion Secretome with Bioactive Molecules & Exosomes R&DPreclinicalPhase 1Phase 2Phase 3In-market Age Spots and AcneNeuropathic PainWound HealingVulva Lichen Planus Partnering with usRegeneus is constantly looking for partners and research collaborators. Contact us for more information. Get in touch